Felipeptin A1+Felipeptin A2

General Information


DRACP ID  DRACP04567

Peptide Name   Felipeptin A1+Felipeptin A2

Sequence  GSRGWGFEPGVRCLIWCD,GGGGRGYEYNKQCLIFC

Sequence Length  36

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  Mix



Physicochemical Information


Formula  C172H249N49O46S4

Absent amino acids  AHMT

Common amino acids  G

Mass  449189

Pl  7.91

Basic residues  4

Acidic residues  3

Hydrophobic residues  9

Net charge  1

Boman Index  -4059

Hydrophobicity  -24.72

Aliphatic Index  51.39

Half Life 
  /

Extinction Coefficient cystines  14230

Absorbance 280nm  406.57

Polar residues  17

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 33294793

Title  Class IV Lasso Peptides Synergistically Induce Proliferation of Cancer Cells and Sensitize Them to Doxorubicin

Doi Not available

Year  2020

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  20592

DRACP is developed by Dr.Zheng's team.